Calling all Investors, Medical Device Innovators, Biotech Entrepreneurs, and Life Sciences Industry Professionals:
Join the Massachusetts life sciences community as the startups from the Cycle 5 Cohort pitch their medical device solution to a panel of judges. These startups are working with M2D2 to advance the commercialization of their technology through the IMPACT Accelerator Program, sponsored by a group of stakeholders from medtech organizations.
AGENDA:
4:00 Registration and networking
5:00 Event start/pitches
7:00 Networking (+ Prize announcements)
8:00 Program close
What is IMPACT?
The M2D2 IMPACT program is a 12-week accelerator program that will run for 6 cycles. The program aims to advance early-stage companies looking to reshape the future of healthcare. Selected companies will have the opportunity to engage with our sponsors’ specialized research calls to help advance their business.
Each IMPACT Cycle closes with an IMPACT Accelerator Pitch-Off. The startups involved in the current cycle will pitch their technology to a panel of experts and innovators on medical device development.
Meet the Startups:
ActivArmor: ActivArmor is launching a digital fabrication system that utilizes the latest 3D scanning and printing technologies with an AI-driven design software to provide patient-specific, custom-fitted casts and splints in waterproof, sanitizable plastics, that allow people to live their active lifestyles while healing.
BonePixel: BonePixel is leveraging existing clinical data for personalized diagnosis and treatment planning of joint injuries using AI and 3D simulation.
BrilliantStrings Therapeutics: BrilliantStrings Therapeutics is developing transformative, direct protein therapies to accelerate the healing of soft connective tissues.
Grace and Able: Grace & Able make joint support that people want to wear: supportive, comfy and stylish. Hand Therapist Designed, Arthritis Patient Approved.
JAM.ai: JAM.ai’s wearable technology enables noninvasive capture of joint and muscle loading for use in optimizing sports performance and enhancing recovery.
KAT Innovation: OSTAAT™ is a bone growth device designed to prevent or accelerate healing of hip fractures in people having osteoporosis with or without chronic renal failure.
911 Medical Devices: 911MD wearable platform is a; novel bandage, a thermal therapeutic dressing, and provides for diagnostic and imaging functionality.
Nanochon: Nanochon is commercializing the Chondrograft(TM) implant for treating arthritic cartilage damage in the knee. The device uses a novel nano-polymer and 3D printing to guide real cartilage growth.
OrthoKinetic Track: OrthoKinetic Track is improving Digital Orthopaedic Care using Smart and Connected Sensor System for Tracking Muscle Activity and Joint Kinematics.
Sonogen Medical, Inc.: Sonogen is commercializing an ultrasonic device that delivers optimized bone fracture healing and real-time fracture healing diagnostics.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
